These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 25956828)
1. In vivo protein targets for increased quinoprotein adduct formation in aged substantia nigra. Yu G; Liu H; Zhou W; Zhu X; Yu C; Wang N; Zhang Y; Ma J; Zhao Y; Xu Y; Liao L; Ji H; Yuan C; Ma J Exp Neurol; 2015 Sep; 271():13-24. PubMed ID: 25956828 [TBL] [Abstract][Full Text] [Related]
2. Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells. Wang N; Wang Y; Yu G; Yuan C; Ma J Neurochem Res; 2011 Nov; 36(11):2169-75. PubMed ID: 21785836 [TBL] [Abstract][Full Text] [Related]
3. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits. Zhang J; Stanton DM; Nguyen XV; Liu M; Zhang Z; Gash D; Bing G Neuroscience; 2005; 135(3):829-38. PubMed ID: 16165292 [TBL] [Abstract][Full Text] [Related]
4. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
5. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related]
8. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons. Hill WD; Arai M; Cohen JA; Trojanowski JQ J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049 [TBL] [Abstract][Full Text] [Related]
9. Local application of L- threo-hydroxyaspartate and malonate in rats in vivo induces rigidity and damages neurons of the substantia nigra, pars compacta. Loopuijt LD J Neural Transm (Vienna); 2002 Oct; 109(10):1275-94. PubMed ID: 12373561 [TBL] [Abstract][Full Text] [Related]
10. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats. Wang YQ; Bian GL; Bai Y; Cao R; Chen LW Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
12. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation. Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539 [TBL] [Abstract][Full Text] [Related]
13. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex. Li H; Dryhurst G J Neural Transm (Vienna); 2001; 108(12):1363-74. PubMed ID: 11810401 [TBL] [Abstract][Full Text] [Related]
14. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors. Andersson DR; Björnsson E; Bergquist F; Nissbrandt H Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096 [TBL] [Abstract][Full Text] [Related]
15. L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein. Kuhn DM; Arthur RE Brain Res Mol Brain Res; 1999 Nov; 73(1-2):78-84. PubMed ID: 10581400 [TBL] [Abstract][Full Text] [Related]
16. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat. Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178 [TBL] [Abstract][Full Text] [Related]
17. Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor. Vaudano E; Rosenblad C; Björklund A Eur J Neurosci; 2001 Jan; 13(1):1-14. PubMed ID: 11134999 [TBL] [Abstract][Full Text] [Related]
18. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease. Shen XM; Li H; Dryhurst G J Neural Transm (Vienna); 2000; 107(8-9):959-78. PubMed ID: 11041275 [TBL] [Abstract][Full Text] [Related]
19. In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state. Calabrese V; Mancuso C; Ravagna A; Perluigi M; Cini C; De Marco C; Butterfield DA; Stella AM J Neurochem; 2007 May; 101(3):709-17. PubMed ID: 17241115 [TBL] [Abstract][Full Text] [Related]
20. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection. Ruano D; Revilla E; Gavilán MP; Vizuete ML; Pintado C; Vitorica J; Castaño A Neuroscience; 2006 Jul; 140(4):1157-68. PubMed ID: 16713109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]